Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 15 studies | 44% ± 20% | |
respiratory goblet cell | 7 studies | 65% ± 13% | |
club cell | 5 studies | 40% ± 24% | |
ionocyte | 5 studies | 38% ± 17% | |
secretory cell | 5 studies | 42% ± 23% | |
basal cell | 4 studies | 24% ± 5% | |
deuterosomal cell | 4 studies | 54% ± 23% | |
epithelial cell | 4 studies | 58% ± 14% | |
squamous epithelial cell | 3 studies | 60% ± 18% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 43% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 41% | 156.98 | 74 / 180 | 97% | 67.91 | 417 / 430 |
lung | 71% | 832.31 | 411 / 578 | 32% | 3.15 | 368 / 1155 |
uterus | 47% | 487.48 | 80 / 170 | 48% | 8.49 | 219 / 459 |
breast | 64% | 400.18 | 294 / 459 | 20% | 2.47 | 225 / 1118 |
thymus | 52% | 173.87 | 342 / 653 | 8% | 0.35 | 51 / 605 |
pancreas | 10% | 8.98 | 33 / 328 | 49% | 5.78 | 87 / 178 |
prostate | 52% | 140.00 | 128 / 245 | 0% | 0.00 | 1 / 502 |
skin | 45% | 67.66 | 823 / 1809 | 0% | 0.00 | 1 / 472 |
adipose | 42% | 2183.25 | 506 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 16% | 97.73 | 226 / 1445 | 19% | 1.40 | 35 / 183 |
bladder | 14% | 7.10 | 3 / 21 | 12% | 1.64 | 60 / 504 |
heart | 18% | 111.52 | 156 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.98 | 8 / 45 |
lymph node | 0% | 0 | 0 / 0 | 17% | 1.46 | 5 / 29 |
intestine | 8% | 9.97 | 74 / 966 | 6% | 0.75 | 32 / 527 |
stomach | 4% | 17.59 | 15 / 359 | 8% | 0.51 | 23 / 286 |
spleen | 8% | 7.13 | 20 / 241 | 0% | 0 | 0 / 0 |
kidney | 4% | 3.87 | 4 / 89 | 2% | 0.08 | 14 / 901 |
blood vessel | 5% | 27.43 | 69 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 5% | 14.55 | 42 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 2% | 2.84 | 6 / 258 | 0% | 0 | 0 / 230 |
liver | 1% | 1.04 | 3 / 226 | 1% | 0.05 | 4 / 406 |
muscle | 1% | 1.76 | 10 / 803 | 0% | 0 | 0 / 0 |
brain | 0% | 1.67 | 13 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007155 | Biological process | cell adhesion |
GO_0005796 | Cellular component | Golgi lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0031982 | Cellular component | vesicle |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | MUC16 |
Protein name | Mucin-16 (MUC-16) (Ovarian cancer-related tumor marker CA125) (CA-125) (Ovarian carcinoma antigen CA125) Mucin-16 long isoform Mucin-16 short isoform Mucin 16, cell surface associated |
Synonyms | CA125 |
Description | FUNCTION: Thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces. . |
Accessions | ENST00000601404.5 ENST00000596768.5 ENST00000397910.8 ENST00000710610.1 ENST00000710609.1 M0R2S7 ENST00000599436.1 Q8WXI7 A0AA34QVW0 A0AA34QW05 M0QZZ9 M0R2Y5 A0A3Q8B178 A0A3S6HTB9 |